Researchers funded by the National Institutes of Health (NIH) have developed a new test, known as the Short-read Transpore Rapid Karyotyping (STORK) test, for the detection of abnormal fetal chromosomes.
The same-day test can also identify extra or missing chromosomes, such as aneuploidy, using samples collected from prenatal tests, including amniocentesis and chorionic villus sampling.
It can also use tissue from miscarriages or biopsies from pre-implantation embryos that have been produced during in vitro fertilisation (IVF).
